TRIM62 and breast carcinoma: Until now, no reports about variants in DEAR1 associated with breast cancer risk adjusted for different epidemiological risk factors had been conducted and it is important to highlight the role of interactions between genotype, risk factors, and breast cancer risk, but the current approaches to identify such interactions are scarce, and new methodologies should be developed.